Blog

Home  >  Resources  >  Blog

Biosimilars are intricate in their makeup and the process for FDA approval is even more multidimensional.  Todd Cooperman’s (PharmD, MBA, R.Ph.) recent whitepaper provides insight into biosimilars in the U.S. healthcare marketplace.  Below is a caption from the introduction of the whitepaper. Initial Food and Drug Administration (FDA) guidance on the biosimilar pathway was intentionally vague, […]

A running theme at the Asembia 2017 Specialty Pharmacy Summit was the explosive growth in attendance from several hundred a few years ago to greater than 6,000 in attendance in 2017.  Pharmaceutical and Biological (Pharma/Bio) manufacturers were the dominant presence at Asembia, which is no surprise given their pricing power in the specialty drug market, […]

RJ Health Systems will be exhibiting at several healthcare trade shows Spring 2017. We will be attending the following tradeshows: 14th Annual World Health Care Congress Convenes decision makers from all sectors of health care to catalyze meaningful partnerships and change. In 2017, faculty focus on policy and market forces impacting the health care business environment […]

Setting a familiar tone for the Specialty Drug landscape, the presentation by Express Scripts during AMCP’s opening session (Speaker: Aimee Tharaldson, PharmD) included staggering cost increases within both the medical and pharmacy benefit, however encouraging news of emerging treatments.  Beyond that “given” (and the fact that oncolytics represent their industry), here are ten (10) observations worth […]

RJ Health Systems is hitting the road this spring! Our team will be attending and exhibiting at several conferences to share our solutions with Payors, PBMs, Specialty Pharmacies, Infusion Companies, Medicaid Organizations, Physicians and Medical Billing companies. Visit our booth to learn how we can help you save time and money managing specialty drug trend. […]

Gain insight on how your organization can apply modest policy adjustments and some straight-forward network engagement tactics to achieve 6% to 10% in savings on Specialty Drug spend. Take the first step to improving medical drug management controls.

Clinical Drug data, which includes Min Max Dosing, Diagnosis Codes, and Age and Gender data, tends to be overlooked on medical drug claims. Health Plans will primarily analyze and review coding and pricing errors because they are directly connected to pricing and their bottom line. However, clinical errors on claim forms can be just as costly. […]

Starting on January 23rd, when you visit ReimbursementCodes.com, you will see a brand new website. When you login to your account at the top of the page you will still be directed to the classic ReimbursementCodes website. This new public site will give you a taste of the new ReimbursementCodes experience coming in the next […]

Having personally dismissed 99% of these CEO missives, I wrestled with the need, never-mind the value of this communication. My objective since taking the reins of RJ Health Systems in 2015 has largely been to distinguish us from the jargon-filled, oftentimes frenzied industry heavyweights we operate alongside in service to Payors and Providers in the […]